Connect with us

Healthcare

Biden vows to publicize review into COVID origins

Published

on

Screen Shot 2020 11 04 at 12.46.15 AM

After President Biden demanded an investigation into the origins of the COVID-19 virus, he also promised to make the findings public in a statement Thursday.

Wednesday, Biden announced that he “asked the Intelligence Community to redouble their efforts to collect and analyze information that could bring us closer to a definitive conclusion.” Biden demanded a report within 90 days.

Biden was about to board Air Force One in Maryland after attending the wake of one of his staffers when a reporter followed up: “What do you expect to get from your review — your 90-day review on where the origins of the coronavirus were?”

He admitted he had no expectations. “If I knew that, I wouldn’t ask for a 90-day review,” Biden replied. “I don’t know.”

“Will you pledge to release it in full?  Will you pledge to release the report in full after 90 days?” the reporter asked.

“Yes,” Biden promised, “unless there’s something I’m unaware of.”

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC